In this Pharma IQ interview David Elder, Director of Product Development, GlaxoSmithKline and Brendan Griffin Lecturer in Pharmaceutics and Course Director University College Cork, discuss how they are tackling major challenges in drug development, such as improving solubility to enhance bioavailability and overcoming poor compound stability. They also share their thoughts on the latest developments in micro and nanoparticle technology and how can they be used for targeted drug delivery and make predictions for the next biggest innovation in targeted drug delivery. Finally they discuss the recent impact of the economic climate and how especially in these unstable economic times academia and industry should work together in drug development collaborations.

[inlinead]
 

Have Your Say
Rate this feature and give us your feedback in the comments section below